Prise en charge chirurgicale des cancers gynécologiques en période de pandémie COVID-19 – Recommandations du Groupe FRANCOGYN pour le CNGOF
| Autor: | Geoffroy Canlorbe, Ludivine Dion, Vincent Lavoué, Emilie Raimond, P. Collinet, Cherif Akladios, Nicolas Bourdel, Yohann Dabi, Chantal Touboul, Olivier Graesslin, Henri Azaïs, Matthieu Mezzadri, Alexandre Bricou, Lise Lecointre, Marcos Ballester, Camille Mimoun, Tristan Gauthier, Frédéric Kridelka, Pauline Chauvet, Pierre-Adrien Bolze, Sofiane Bendifallah, Xavier Carcopino, C. Huchon, Charles Coutant, M. Koskas, L. Ouldamer |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cervical cancer
medicine.medical_specialty 030219 obstetrics & reproductive medicine Hysterectomy medicine.diagnostic_test business.industry General surgery medicine.medical_treatment Endometrial cancer Sentinel lymph node Obstetrics and Gynecology Cancer medicine.disease Radiation therapy 03 medical and health sciences 0302 clinical medicine Reproductive Medicine 030220 oncology & carcinogenesis Obstetrics and Gynaecology medicine Hyperthermic intraperitoneal chemotherapy business Endometrial biopsy |
| Zdroj: | Gynécologie Obstétrique Fertilité & Sénologie |
| ISSN: | 2468-7189 |
| Popis: | INTRODUCTION: Recommendations for the management of patients with gynecological cancer during the COVID-19 pandemic period. MATERIAL AND METHOD: Recommendations based on the consensus conference model. RESULTS: In the case of a COVID-19 positive patient, surgical management should be postponed for at least 15 days. For cervical cancer, the place of surgery must be re-evaluated in relation to radiotherapy and Radio-Chemotherapy-Concomitant and the value of lymph node staging surgeries must be reviewed on a case-by-case basis. For advanced ovarian cancers, neo-adjuvant chemotherapy should be favored even if primary cytoreduction surgery could be envisaged. It is lawful not to offer hyperthermic intraperitoneal chemotherapy during a COVID-19 pandemic. In the case of patients who must undergo interval surgery, it is possible to continue the chemotherapy and to offer surgery after 6 cycles of chemotherapy. For early stage endometrial cancer, in case of low and intermediate preoperative ESMO risk, hysterectomy with bilateral annexectomy associated with a sentinel lymph node procedure should be favored. It is possible to consider postponing surgery for 1 to 2 months in low-risk endometrial cancers (FIGO Ia stage on MRI and grade 1-2 endometrioid cancer on endometrial biopsy). For high ESMO risk, it ispossible to favor the MSKCC algorithm (combining PET-CT and sentinel lymph node biopsy) in order to omit pelvic and lumbar-aortic lymphadenectomies. CONCLUSION: During COVID-19 pandemic, patients suffering from cancer should not lose life chance, while limiting the risks associated with the virus. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect